[논문]COVID-19: an update on diagnostic and therapeutic approaches

Iyer, Mahalaxmi; Jayaramayya, Kaavya; Subramaniam, Mohana Devi; Lee, Soo Bin; Dayem, Ahmed Abdal; Cho, Ssang-Goo; Vellingiri, Balachandar

doi:10.5483/bmbrep.2020.53.4.080

COVID-19: an update on diagnostic and therapeutic approaches 원문보기

BMB reports, v.53 no.4, 2020년, pp.191 - 205

Iyer, Mahalaxmi (Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women) , Jayaramayya, Kaavya (Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women) , Subramaniam, Mohana Devi (Department of Genetics and Molecular Biology, Vision Research Foundation) , Lee, Soo Bin (Department of Stem Cell and Regenerative Biotechnology, Konkuk University) , Dayem, Ahmed Abdal (Department of Stem Cell and Regenerative Biotechnology, Konkuk University) , Cho, Ssang-Goo (Department of Stem Cell and Regenerative Biotechnology, Konkuk University) , Vellingiri, Balachandar (Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University)

Abstract ▼ AI-Helper

The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide. COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease. In such a pandemic situation, various steps have been taken by the government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This pandemic situation has forced scientists to rework strategies to combat infectious diseases through drugs, treatment, and control measures. COVID-19 treatment requires both limiting viral multiplication and neutralizing tissue damage induced by an inappropriate immune reaction. Currently, various diagnostic kits to test for COVID-19 are available, and repurposing therapeutics for COVID-19 has shown to be clinically effective. As the global demand for diagnostics and therapeutics continues to rise, it is essential to rapidly develop various algorithms to successfully identify and contain the virus. This review discusses the updates on specimens/samples, recent efficient diagnostics, and therapeutic approaches to control the disease and repurposed drugs mainly focusing on chloroquine/hydroxychloroquine and convalescent plasma (CP). More research is required for further understanding of the influence of diagnostics and therapeutic approaches to develop vaccines and drugs for COVID-19.

주제어

참고문헌 (43)

1 World Health Organization 2020 https://www.who.int/emergencies/diseases/novel-coronavirus-2019 accessed on 21 April, 2020
2 Balachandar V Kaavya J Mahalaxmi I 2020 COVID-19: A promising cure for the global panic Sci Total Environ [Online ahead of print] 10.1016/j.scitotenv.2020.138277 32278175

상세보기
3 Zheng F Tang W Li H Huang Y Xie Y Zhou Z 2020 Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha Eur Rev Med Pharmacol Sci 24 3404 3410 10.26355/eurrev_202003_20711 32271459
4 Balachandar V Mahalaxmi I Kaavya J 2020 COVID-19: Emerging protective measures Eur Rev Med Pharmaco 24 3422 3425 10.26355/eurrev_202003_20713 32271461
5 Rothe C Schunk M Sothmann P 2020 Transmission of 2019-nCoV infection from an asymptomatic contact in Germany N Engl J Med 382 970 971 10.1056/NEJMc2001468 32003551

상세보기
6 Callaway E Cyranoski D 2020 China coronavirus: six questions scientists are asking Nature 577 605 607 10.1038/d41586-020-00166-6 31992880

상세보기
7 Huang C Wang Y Li X 2020 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 395 497 506 10.1016/S0140-6736(20)30183-5 31986264

상세보기
8 Centers for Disease Prevention and Control (CDC) 2020 Interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19) https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html accessed on 16 April, 2020
9 World Health Organization (WHO) 2020 Advice on the use of point-of-care immunodiagnostic tests for COVID-19 https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19 accessed on 21 April, 2020
10 Indian Council of Medical Research (ICMR) 2020 https://icmr.nic.in/sites/default/files/upload_documents/Validation_of_Commercial_Kits_02042020.pdf accessed on 16 April, 2020
11 World Health Organization (WHO) 2020 Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical guidance/laboratory-guidance accessed on 21 April, 2020
12 Cao Y Liu X Xiong L Cai K 2020 Imaging and clinical features of patients with 2019 novel coronavirus SARS CoV2: a systematic review and metaanalysis J Med Virol [Online ahead of print] 10.1002/jmv.25822 32242947

상세보기
13 Zhou F Yu T Du R 2020 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054 1062 10.1016/S0140-6736(20)30566-3 32171076

상세보기
14 Cao J Tu WJ Cheng W Yu L Tu WJ Liu Q 2020 Clinical features and short-term outcomes of 102 patients with corona virus disease 2019 in Wuhan, China Clin Infect Dis [Online ahead of print] 10.1093/cid/ciaa243 32239127

상세보기
15 World Health Organization (WHO) 2020 "Solidarity" clinical trial for COVID-19 treatments https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments accessed on 16 April, 2020
16 Stebbing J Phelan A Griffin I Tucker C Oechsle O Smith D Richardson P 2020 COVID-19: combining antiviral and anti-inflammatory treatments Lancet Infect Dis 20 400 402 10.1016/S1473-3099(20)30132-8 32113509

상세보기
17 2012- Bethesda, LiverTox: Clinical and Research Information on Drug-Induced liver injury [Internet] National Institute of Diabetes and Digestive and Kidney Diseases Bethesda (MD) 2017 Feb 2
18 Plantone D Koudriavtseva T 2018 Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic and neurological diseases: A Mini-Review Clin Drug Investig 38 653 671 10.1007/s40261-018-0656-y 29737455

상세보기
19 Yan Y Zou Z Sun Y 2013 Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model Cell Res 23 300 302 10.1038/cr.2012.165 23208422

상세보기
20 Li C Zhu X Ji X 2017 Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice EBioMedicine 24 189 194 10.1016/j.ebiom.2017.09.034 29033372

상세보기
21 Shiryaev SA Mesci P Pinto A 2017 Repurposing of the anti-malaria drug chloroquine for Zika virus treatment and prophylaxis Sci Rep 7 15771 10.1038/s41598-017-15467-6 29150641

상세보기
22 Yao X Ye F Zhang M 2020 In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis [Online ahead of print] 10.1093/cid/ciaa237 32150618

상세보기
23 Gao J Tian Z Yang X 2020 Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Biosci Trends 14 72 73 10.5582/bst.2020.01047 32074550

상세보기
24 Savarino A Di Trani L Donatelli I Cauda R Cassone A 2006 New insights into the antiviral effects of chloroquine Lancet Infect Dis 6 67 69 10.1016/S1473-3099(06)70361-9 16439323

상세보기
25 Ducharme J Farinotti R 1996 Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements Clin Pharmacokinet 31 257 274 10.2165/00003088-199631040-00003 8896943

상세보기
26 Wang M Cao R Zhang L 2020 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Cell Res 30 269 271 10.1038/s41422-020-0282-0 32020029

상세보기
27 Vincent MJ Bergeron E Benjannet S 2005 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Virol J 2 69 10.1186/1743-422X-2-69 16115318

상세보기
28 Devaux CA Rolain JM Colson P Raoult D 2020 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents [Online ahead of print] 10.1016/j.ijantimicag.2020.105938 32171740

상세보기
29 Savarino A Boelaert JR Cassone A Majori G Cauda R 2003 Effectd of chloroquine on viral infections: an old drug against today's diseases Lancet Infect Dis 3 722 727 10.1016/S1473-3099(03)00806-5 14592603

상세보기
30 Wang LS Wang YR Ye DW Liu QQ 2020 A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence Int J Antimicrob Agents [Online ahead of print] 10.1016/j.ijantimicag.2020.105948 32201353

상세보기
31 Gautret P Lagier JC Parola P 2020 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Int J Antimicrob Agents [Online ahead of print] 10.1016/j.ijantimicag.2020.105949 32205204

상세보기
32 Luke T Kilbane E Jackson J Ho？man S 2006 Meta-analysis: convalescent blood products for Spanish in？uenza pneumonia: a future H5N1 treatment? Ann Intern Med 145 599 609 10.7326/0003-4819-145-8-200610170-00139 16940336

상세보기
33 Van Griensven J Edwards T de Lamballerie X 2016 Evaluation of convalescent plasma for Ebola virus disease in Guinea N Engl J Med 374 33 42 10.1056/NEJMoa1511812 26735992

상세보기
34 Zhou B Zhong N Guan Y 2007 Treatment with convalescent plasma for in？uenza A (H5N1) infection N Engl J Med 357 1450 1451 10.1056/NEJMc070359 17914053

상세보기
35 Mair-Jenkins J Saavedra-Campos M Baillie JK 2015 The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis J Infect Dis 211 80 90 10.1093/infdis/jiu396 25030060

상세보기
36 Hung IF To KK Lee CK 2011 Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection Clin Infect Dis 52 447 456 10.1093/cid/ciq106 21248066

상세보기
37 Cheng Z Lu Y Cao Q 2020 Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China Am J Roentgenol [Online ahead of print] 10.2214/AJR.20.22959 32174128

상세보기
38 Ko JH Seok H Cho SY 2018 Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience Antivir ther 23 617 622 10.3851/IMP3243 29923831

상세보기
39 Lee PI Hsueh PR 2020 Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV J Microbiol Immunol Infect [Online ahead of print] 10.1016/j.jmii.2020.02.001 32035811

상세보기
40 Chen L Xiong J Bao L Shi Y 2020 Convalescent plasma as a potential therapy for COVID-19 Lancet Infect Dis 20 398 400 10.1016/S1473-3099(20)30141-9 32113510

상세보기
41 Bobati SS Naik KR 2017 Therapeutic plasma exchange - an emerging treatment modality in patients with neurologic and non-neurologic diseases J Clin Diagn Res 11 EC35 EC37 10.7860/JCDR/2017/27073.10480 28969140
42 Duan K Liu B Li C 2020 Effectiveness of convalescent plasma therapy in severe COVID-19 patients Proc Natl Acad Sci U S A [Online ahead of print] 10.1073/pnas.2004168117 32253318

상세보기
43 Liu J Cao R Xu M 2020 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Cell Discov 6 16 10.1038/s41421-020-0156-0 32194981

상세보기

LOADING...

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

COVID-19: an update on diagnostic and therapeutic approaches 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (43)

이 논문을 인용한 문헌

연구과제 타임라인

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

연합인증

COVID-19: an update on diagnostic and therapeutic approaches 원문보기

Abstract ▼ AI-Helper

주제어

참고문헌 (43)

이 논문을 인용한 문헌

연구과제 타임라인

전체(0) 논문(0) 특허(0) 보고서(0)

전체(0) 논문(0) 특허(0) 보고서(0)

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트